• Xydia M, Rahbari R, Ruggiero E, Macaulay I, Tarabichi M, Lohmayer R, Wilkening S, Michels T, Brown D, Vanuytven S, Mastitskaya S, Laidlaw S, Grabe N, Pritsch M, Fronza R, Hexel K, Schmitt S, Müller-Steinhardt M, Halama N, Domschke C, Schmidt M, von Kalle C, Schütz F, Voet T and Beckhove P. Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients. Nature Communications, accepted.
  • Patasic L, Seifried J, Bezler V, Kaljanac M, Schneider IC, Schmitz H, Tondera C, Hartmann J, Hombach A, Buchholz CJ, Abken H, König R, Cichutek K. Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4+ T cells to reduce the latent HIV+ cell reservoir. Med Microbiol Immunol. 2020 Dec; 209(6):681-691. doi: 10.1007/s00430-020-00692-0. Epub 2020 Sep 12. PMID: 32918599; PMCID: PMC7568711.
  • Safi S, Yamauchi Y, Hoffmann H, Weichert W, Jost PJ, Winter H, Muley T, Beckhove P. Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer. Cancers (Basel). 2020 Nov 24; 12(12):3496. doi: 10.3390/cancers12123496. PMID: 33255425.
  • Guendel F, Kofoed-Branzk M, Gronke K, Tizian C, Witkowski M, Cheng HW, Heinz GA, Heinrich F, Durek P, Norris PS, Ware CF, Ruedl C, Herold S, Pfeffer K, Hehlgans T, Waisman A, Becher B, Giannou AD, Brachs S, Ebert K, Tanriver Y, Ludewig B, Mashreghi MF, Kruglov AA, Diefenbach A. Group 3 Innate Lymphoid Cells Program a Distinct Subset of IL-22BP-Producing Dendritic Cells Demarcating Solitary Intestinal Lymphoid Tissues. Immunity. 2020 Nov 17;53(5):1015-1032.e8. doi: 10.1016/j.immuni.2020.10.012. PMID: 33207209.
  • Fiedler M, Schulz D, Piendl G, Brockhoff G, Eichberger J, Menevse AN, Beckhove P, Hautmann M, Reichert TE, Ettl T, Bauer RJ. Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines. Exp Cell Res. 2020 Nov 1; 396(1):112259. doi: .1016/j.yexcr.2020.112259. Epub 2020 Sep 6. PMID: 32898555
  • Vordenbäumen S, Rosenbaum A, Gebhard C, Raithel J, Sokolowski A, Düsing C, Chehab G, Richter JG, Brinks R, Rehli M, Schneider M., Associations of site-specific CD4 +-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus., Lupus. 2020 Oct 20:961203320965690. doi: 10.1177/0961203320965690. Online ahead of print.
  • Ammer LM, Vollmann-Zwerenz A, Ruf V, Wetzel CH, Riemenschneider MJ, Albert NL, Beckhove P, Hau P. The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma. Cancers (Basel). 2020 Oct 14;12(10):2973. doi: 10.3390/cancers12102973. PMID: 33066460.
  • Galletti G, De Simone G, Mazza EMC, Puccio S, Mezzanotte C, Bi TM, Davydov AN, Metsger M, Scamardella E, Alvisi G, De Paoli F, Zanon V, Scarpa A, Camisa B, Colombo FS, Anselmo A, Peano C, Polletti S, Mavilio D, Gattinoni L, Boi SK, Youngblood BA, Jones RE, Baird DM, Gostick E, Llewellyn-Lacey S, Ladell K, Price DA, Chudakov DM, Newell EW, Casucci M, Lugli E. Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans. Nat Immunol. 2020 Oct 12. doi: 10.1038/s41590-020-0791-5. Epub ahead of print. PMID: 33046887.
  • Dragon AC, Zimmermann K, Nerreter T, Sandfort D, Lahrberg J, Klöß S, Kloth C, Mangare C, Bonifacius A, Tischer-Zimmermann S, Blasczyk R, Maecker-Kolhoff B, Uchanska-Ziegler B, Abken H, Schambach A, Hudecek M, Eiz-Vesper B. CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation. J Immunother Cancer. 2020 Oct; 8(2):e000736. doi: 10.1136/jitc-2020-000736. PMID: 33127653.
  • Wolff D, Bardak J, Edinger M, Klinger-Schindler U, Holler E, Lawitschka A, Schoemans H, Herr W, Kröger N, Ayuk Ayuketang F. Evaluation of the Cost of Survivorship Care After Allogeneic Hematopoeitic Stem Cell Transplantation-An Analysis of 2 German Transplantation Centers. Front Public Health. 2020 Sep 25; 8:572470. doi: 10.3389/fpubh.2020.572470. PMID: 33072711; PMCID: PMC7544947.
  • Nemade H, Acharya A, Chaudhari U, Nembo E, Nguemo F, Riet N, Abken H, Hescheler J, Papadopoulos S, Sachinidis A. Correction: Nemade, H.; et al. Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells. Cells 2020, 9, 554. Cells. 2020 Sep 24; 9(10):E2165. doi: 10.3390/cells9102165. Erratum for: Cells. 2020 Feb 27; 9(3): PMID: 32987940; PMCID: PMC7599753.
  • Oberbeck S, Schrader A, Warner K, Jungherz D, Crispatzu G, von Jan J, Chmielewski M, Ianevski A, Diebner HH, Mayer P, Kondo Ados A, Wahnschaffe L, Braun T, Müller TA, Wagle P, Bouska A, Neumann T, Pützer S, Varghese L, Pflug N, Thelen M, Makalowski J, Riet N, Göx HJM, Rappl G, Altmüller J, Kotrova M, Persigehl T, Hopfinger G, Hansmann ML, Schlößer H, Stilgenbauer S, Dürig J, Mougiakakos D, von Bergwelt-Baildon M, Roeder I, Hartmann S, Hallek M, Moriggl RH, Brüggemann M, Aittokallio T, Iqbal J, Newrzela S, Abken H, Herling M. Non-canonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling. Blood. 2020 Sep 21:blood.2019003348. doi: 10.1182/blood.2019003348. Epub ahead of print. PMID: 32959065.
  • Chanyalew M, Abebe M, Endale B, Girma S, Tasew G, van Zandbergen G, Ritter U, Gadisa E, Aseffa A, Laskay T. Enhanced production of pro-inflammatory cytokines and chemokines in Ethiopian cutaneous leishmaniasis upon exposure to Leishmania aethiopica. Cytokine. 2020 Sep 18:155289. doi: 10.1016/j.cyto.2020.155289. Online ahead of print. PMID: 32951968
  • Fante MA, Holler B, Weber D, Angstwurm K, Bergler T, Holler E, Edinger M, Herr W, Wertheimer T, Wolff D. Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis. Ann Hematol. 2020 Sep; 99(9):2181-2190. doi: 10.1007/s00277-020-04193-1. Epub 2020 Jul 26. PMID: 32715339; PMCID: PMC7419371.
  • Volpin V, Michels T, Sorrentino A, Menevse AN, Knoll G, Ditz M, Milenkovic VM, Chen CY, Rathinasamy A, Griewank K, Boutros M, Haferkamp S, Berneburg M, Wetzel CH, Seckinger A, Hose D, Goldschmidt H, Ehrenschwender M, Witzens-Harig M, Szoor A, Vereb G, Khandelwal N, Beckhove P. CAMK1D triggers immune resistance of human tumor cells refractory to anti-PD-L1 treatment. Cancer Immunol Res 2020 Sep; 8(9):1163-1179. doi: 10.1158/2326-6066.CIR-19-0608. Epub 2020 Jul 14. PMID: 32665263
  • Tasew G, Gadisa E, Abera A, Chanyalew M, Abebe M, Howe R, Ritter U, Aseffa A, Laskay T. Whole blood-based in vitro culture reveals diminished secretion of pro-inflammatory cytokines and chemokines in visceral leishmaniasis. Cytokine. 2020 Aug 19:155246. doi: 10.1016/j.cyto.2020.155246. Online ahead of print. PMID: 32828639
  • Szöőr Á, Tóth G, Zsebik B, Szabó V, Eshhar Z, Abken H, Vereb G. Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies. Cancer Lett. 2020 Aug 1; 484:1-8. doi: 10.1016/j.canlet.2020.04.008. Epub 2020 Apr 11. PMID: 32289441.
  • Alzubi J, Dettmer-Monaco V, Kuehle J, Thorausch N, Seidl M, Taromi S, Schamel W, Zeiser R, Abken H, Cathomen T, Wolf P. PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. Mol Ther Oncolytics. 2020 Jun 24; 18:226-235. doi: 10.1016/j.omto.2020.06.014. PMID: 32728611; PMCID: PMC7372156.
  • Gran C, Wang J, Nahi H, Koster L, Gahrton G, Einsele H, Niittyvoupio R, Edinger M, Beelen D, Ciceri F, Bornhäuser M, Finke J, de Wreede LC, Ljungman P, Mielke S, Tischer J, Garderet L, Schönland S, Yakoub-Agha I, Kröger N. Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT. Br J Haematol. 2020 Jun;189(5):e213-e217. doi: 10.1111/bjh.16642. Epub 2020 Apr 16. PMID: 32301111.
  • Delacher M, Barra MM, Herzig Y, Eichelbaum K, Rafiee MR, Richards DM, Träger U, Hofer AC, Kazakov A, Braband KL, Gonzalez M, Wöhrl L, Schambeck K, Imbusch CD, Abramson J, Krijgsveld J, Feuerer M. Quantitative Proteomics Identifies TCF1 as a Negative Regulator of Foxp3 Expression in Conventional T Cells. iScience. 2020 May 22; 23(5):101127. doi: 10.1016/j.isci.2020.101127. Epub 2020 May 4. PMID: 32422593; PMCID: PMC7229326.
  • Klobuch S, Hammon K, Vatter-Leising S, Neidlinger E, Zwerger M, Wandel A, Neuber LM, Heilmeier B, Fichtner R, Mirbeth C, Herr W, Thomas S. HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation. Cells. 2020 May 20; 9(5):1264. doi: 10.3390/cells9051264. PMID: 32443793; PMCID: PMC7290340.
  • Sawitzki B, Harden PN, Reinke P, Moreau A, Hutchinson JA, Game DS, Tang Q, Guinan EC, BattagliaM, Burlingham WJ, Roberts ISD, Streitz M, Josien R, Böger CA, Scottà C,Markmann JF, Hester JL, Juerchott K, Braudeau C, James B, Contreras-Ruiz L, van der Net JB, Bergler T, Caldara R, Petchey W, Edinger M, Dupas N, Kapinsky M, Mutzbauer I, Otto NM, Öllinger R, Hernandez-Fuentes MP, Issa F, Ahrens N, Meyenberg C, Karitzky S, Kunzendorf U, Knechtle SJ, Grinyó J, Morris PJ, Brent L, Bushell A, Turka LA, Bluestone JA, Lechler RI, Schlitt HJ, Cuturi MC, Schlickeiser S, Friend PJ, Miloud T, Scheffold A, Secchi A, Crisalli K, Kang SM, Hilton R, Banas B, Blancho G, Volk HD, Lombardi G, Wood KJ, Geissler EK., Regulatorycell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials. Lancet. 2020 May 23; 395(10237):1627-1639. doi: 10.1016/S0140-6736(20)30167-7.
  • Siska PJ, Singer K, Evert K, Renner K, Kreutz M. The immunological Warburg effect: Can a metabolic-tumor-stroma score (MeTS) guide cancer immunotherapy? Immunol Rev. 2020 May; 295(1):187-202. doi: 10.1111/imr.12846. Epub 2020 Mar 10. PMID: 32157706.
  • Strandt H, Voluzan O, Niedermair T, Ritter U, Thalhamer J, Malissen B, Stoecklinger A, Henri S. Macrophages and Fibroblasts Differentially Contribute to Tattoo Stability. Dermatology. 2020 Apr 28:1-7. doi: 10.1159/000506540. Online ahead of print. PMID: 32344413
  • Chmielewski, M., Abken, H., TRUCKS, the fourth generation CAR T cells: current developments and clinical translation. Adv. Cell Gene Ther., 00:e84 (24 April 2020), doi.org/10.1002/acg2.84
  • Haumann S, Boix J, Knuever J, Bieling A, Vila Sanjurjo A, Elson JL, Blakely EL, Taylor RW, Riet N, Abken H, Kashkar H, Hornig-Do HT, Wiesner RJ. Mitochondrial DNA mutations induce mitochondrial biogenesis and increase the tumorigenic potential of Hodgkin and Reed-Sternberg cells. Carcinogenesis. 2020 Apr 7:bgaa032. doi: 10.1093/carcin/bgaa032. Epub ahead of print. PMID: 32255484.
  • Hombach, A.A., Geumann, U., Günther, C., Hermann, F.G., Abken, H., IL7-IL12 engineered mesenchymal stem cells (MSCs) improve a CAR T cell attack against colorectal cancer cells. Cells. 2020 Apr 3; 9(4):873. doi: 10.3390/cells9040873.
  • Kattner AS, Holler E, Holler B, Klobuch S, Weber D, Martinovic D, Edinger M, Herr W, Wolff D. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Ann Hematol. 2020 Apr; 99(4):847-853. doi: 10.1007/s00277-020-03968-w. Epub 2020 Feb 21. PMID: 32086584; PMCID: PMC7069928.
  • Hermans D, Gautam S, García-Cañaveras JC, Gromer D, Mitra S, Spolski R, Li P, Christensen S, Nguyen R, Lin JX, Oh J, Du N, Veenbergen S, Fioravanti J, Ebina-Shibuya R, Bleck C, Neckers LM, Rabinowitz JD, Gattinoni L, Leonard WJ. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity. Proc Natl Acad Sci U S A. 2020 Mar 17; 117(11):6047-6055. doi: 10.1073/pnas.1920413117. Epub 2020 Mar 2. PMID: 32123114; PMCID: PMC7084161.
  • Gloger M, Menzel L, Grau M, Vion AC, Anagnostopoulos I, Zapukhlyak M, Gerlach K, Kammertöns T, Hehlgans T, Zschummel M, Lenz G, Gerhardt H, Höpken UE, Rehm A. Lymphoma Angiogenesis Is Orchestrated by Noncanonical Signaling Pathways. Cancer Res. 2020 Mar 15;80(6):1316-1329. doi: 10.1158/0008-5472.CAN-19-1493. Epub 2020 Jan 13. PMID: 31932457
  • Riegel C, Boeld TJ, Doser K, Huber E, Hoffmann P, Edinger M. Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells. Leukemia. 2020 Mar; 34(3):895-908. doi: 10.1038/s41375-019-0625-3.
  • Beckhove P, Edinger M, Feuerer M, Gattinoni L, Abken H. International Regensburg Center for Interventional Immunology (RCI) symposium on "Synthetic immunology and environment-adapted redirection of T cells", 17-18 July, 2019, Regensburg, Germany. Cancer Immunol Immunother. 2020 Apr; 69(4):677-682. doi: 10.1007/s00262-019-02467-w. Epub 2020 Mar 2. PMID: 32123937; PMCID: PMC7113201.
  • Nemade H, Acharya A, Chaudhari U, Nembo E, Nguemo F, Riet N, Abken H, Hescheler J, Papadopoulos S, Sachinidis A. Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells. Cells. 2020 Feb 27; 9(3):554. doi: 10.3390/cells9030554. Erratum in: Cells. 2020 Sep 24; 9(10): PMID: 32120775; PMCID: PMC7140528.
  • Zimmermann K, Kuehle J, Dragon AC, Galla M, Kloth C, Rudek LS, Sandalcioglu IE, Neyazi B, Moritz T, Meyer J, Rossig C, Altvater B, Eiz-Vesper B, Morgan MA, Abken H, Schambach A. Design and Characterization of an "All-in-One" Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines. Cancers (Basel). 2020 Feb 6; 12(2):375. doi: 10.3390/cancers12020375. PMID: 32041222; PMCID: PMC7072617.
  • Tóth G, Szöllősi J, Abken H, Vereb G, Szöőr Á. A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts. Int J Mol Sci. 2020 Feb 4; 21(3):1039. doi: 10.3390/ijms21031039. PMID: 32033208; PMCID: PMC7038081.
  • Nikolouli E, Elfaki Y, Herppich S, Schelmbauer C, Delacher M, Falk C, Mufazalov IA, Waisman A, Feuerer M, Huehn J. Recirculating IL-1R2+ Tregs fine-tune intrathymic Treg development under inflammatory conditions. Cell Mol Immunol. 2020 Jan 27. doi: 10.1038/s41423-019-0352-8. Epub ahead of print. PMID: 31988493.
  • Minderjahn J, Schmidt A, Fuchs A, Schill R, Raithel J, Babina M, Schmidl C, Gebhard C, Schmidhofer S, Mendes K, Ratermann A, Glatz D, Nützel M, Edinger M, Hoffmann P, Spang R, Längst G, Imhof A, Rehli M., Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1., Nat Commun. 2020 Jan 21; 11(1):402. doi: 10.1038/s41467-019-13960-2.
  • Delacher M, Imbusch C, Hotz-Wagenblatt A, Mallm J, Bauer K, Simon M, Riegel D, Rendeiro A, Bittner S, Sanderink L, Pant A, Schmidleithner L, Braband K, Echtenachter B, Fischer A, Giunchiglia V, Hoffmann P, Edinger M, Bock C, Rehli M, Brors B, Schmidl C, Feuerer M. Precursors for nonlymphoid-tissue Treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. Immunity. 2020 Jan 2. pii: S1074-7613(19)30498-4.
  • Rendeiro AF*, Krausgruber T*, Fortelny N, Zhao F, Penz T, Farlik M, Schuster LC, Nemc A, Tasnády S, Réti M, Mátrai Z, Alpar D#, Bödör C#, Schmidl C#, Bock C#. Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia. 2020. Nat Commun 11:577
  • Feldker N, Ferrazzi F, Schuhwerk H, Widholz SA, Guenther K, Frisch I, Jakob K, Kleemann J, Riegel D, Bönisch U, Lukassen S, Eccles RL, Schmidl C, Stemmler MP, Brabletz T, Brabletz S. 2020. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer. EMBO 1;39(17):e103209
  • Krausgruber T*, Fortelny N*, Fife-Gernedl V, Senekowitsch M, Schuster LC, Lercher A, Nemc A, Schmidl C, Rendeiro AF, Bergthaler A, Bock C. 2020. Structural cells are key regulators of organ-specific immune response. Nature 583:296-302
  • Hubmann R, Schnabl S, Araghi M, Schmidl C, Rendeiro AF, Hilgarth M, Demirtas D, Farghaly A, Staber PB, Valent P, Zielinski C, Jäger U, Shehata M. 2020. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL. Cells 9(6):E1484
  • Jühling F*, Hamdane N*, Crouchet E*, Li S*, El Saghire H, Mukherji A, Fujiwara N, Oudot MA, Thumann C, Saviano A, Roca Suarez AA, Goto K, Masia R, Sojoodi M, Arora G, Aikata H, Ono A, Tabrizian P, Schwartz M, Polyak SJ, Davidson I, Schmidl C, Bock C, Schuster C, Chayama K, Pessaux P, Tanabe KK, Hoshida Y, Zeisel MB, Duong FH, Fuchs BC, Baumert TF. 2020. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma. Gut 26:gutjnl-2019-318918
  • Holzinger A, Abken H. Advances and Challenges of CAR T Cells in Clinical Trials. Recent Results Cancer Res. 2020; 214:93-128. doi: 10.1007/978-3-030-23765-3_3. PMID: 31473850.
  • Holzinger, A., Abken, H., Chimeric antigen receptor (CAR) redirected T cells. In: Introduction to Antibody Engineering, Ed. Florian Rüker and Gordana Wozniak-Knopp, Springer (2020) ISSN 2509-6125, ISBN 978-3-030-54629-8, doi.org/10.1007/978-3-030-54630-4.
Anfahrt